Bicycle Therapeutics logo

BCYC - Bicycle Therapeutics News Story

$30.94 -0.2  -0.8%

Last Trade - 9:00pm

Sector
Healthcare
Size
Mid Cap
Market Cap £532.6m
Enterprise Value £414.5m
Revenue £7.85m
Position in Universe 3115th / 6846

BRIEF-Bicycle Therapeutics Reports Q4 Loss Per Share $0.83

Thu 11th March, 2021 1:05pm
March 11 (Reuters) - Bicycle Therapeutics PLC  BCYC.O :
    * Q4 NET LOSS -17.4 MILLION USD
    * Q4 DILUTED LOSS PER SHARE 0.83 USD
    * SIGNIFICANT PROGRESS ACHIEVED ACROSS PIPELINE OF BICYCLE
TOXIN
CONJUGATES AND TUMOR TARGETED IMMUNE CELL AGONISTS
    * CASH OF $136.0 MILLION AT DECEMBER 31, 2020 EXPECTED TO
PROVIDE
FINANCIAL RUNWAY THROUGH MULTIPLE CLINICAL MILESTONES

Source text for Eikon:  ID:nBw5Cc0FMa 
Further company coverage:  BCYC.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.